CICATRICURE GOLD DAY WITH SPF- avobenzone, homosalate, octocrylene, octisalate and sulisobenzone cream 
Genomma Lab USA

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Cicatricure® Gold Day Cream With SPF

Drug Facts

Active ingredientsPurpose
Avobenzone 3%Sunscreen
Homosalate 6%Sunscreen
Octocrylene 10%Sunscreen
Octisalate 5%Sunscreen
Sulisobenzone 3%Sunscreen

Uses

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use

  • apply generously and evenly 15 minutes before sun exposure. Reapply at least every 2 hours
  • use a water resistant sunscreen if swimming or sweating.

Sun Protection Measures

Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other skin protection measures including:

  • limit time in the sun, especially from 10am to 2pm
  • wear long-sleeved shirts, pants, hats and sunglasses
  • children under 6 months of age: ask a doctor

Other information

Inactive ingredients

Aqua, Glycerin, Dicaprylyl Carbonate, Polymethylsilsesquioxane, Caprylic/Capric Triglyceride, Caprylyl Methicone, Phenoxyethanol, Glyceryl Stearate, Cetyl Alcohol, Potassium Cetyl Phosphate, Sodium Polyacrylate, Dimethicone, PEG-75 Stearate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Xanthan Gum, Parfum, Ceteth-20, Cyclopentasiloxane, Disodium EDTA, Steareth-20, Ethylhexylglycerin, Sodium Hydroxide, Paeonia Albiflora Root Extract, PEG/PPG-18/18 Dimethicone, Trideceth-6, Hyaluronic Acid, Silanetriol, Iron Oxides (CI 77492, CI 77491), Calcium Chloride, N-Prolyl Palmitoyl Tripeptide-56 Acetate, Bis-Hydroxyethoxypropyl Dimethicone/PEG-2 Soyamine/IPDI Copolymer, Isopropyl Titanium Triisostearate, Colloidal Gold, Acetyl Heptapeptide-9, Alpha-Isomethyl Ionone, Citronellol, Limonene.

Questions?

Call toll free 1 877-994-3666 Monday to Friday, 8am to 6pm, Central time

Distributed by:
Genomma Lab USA Inc.
Houston, TX 77027

PRINCIPAL DISPLAY PANEL - 50 g Jar Carton

Cicatricure®

GOLD LIFT
WITH SUNSCREEN

DAY CREAM WITH SPF 30

REDUCES THE APPEARANCE
OF GRAVITATIONAL WRINKLES
IN 6 WEEKS*

LIFTING EFFECT + NOURISHMENT
LIFTS FACIAL CONTOUR

Net Wt. 1.7 OZ (50g)

* Based on consumer study. Results may vary.

PRINCIPAL DISPLAY PANEL - 50 g Jar Carton
CICATRICURE GOLD DAY WITH SPF 
avobenzone, homosalate, octocrylene, octisalate and sulisobenzone cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:50066-706
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Avobenzone (UNII: G63QQF2NOX) (Avobenzone - UNII:G63QQF2NOX) Avobenzone30 mg  in 1 g
Homosalate (UNII: V06SV4M95S) (Homosalate - UNII:V06SV4M95S) Homosalate60 mg  in 1 g
Octocrylene (UNII: 5A68WGF6WM) (Octocrylene - UNII:5A68WGF6WM) Octocrylene100 mg  in 1 g
Octisalate (UNII: 4X49Y0596W) (Octisalate - UNII:4X49Y0596W) Octisalate50 mg  in 1 g
Sulisobenzone (UNII: 1W6L629B4K) (Sulisobenzone - UNII:1W6L629B4K) Sulisobenzone30 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
glycerin (UNII: PDC6A3C0OX)  
Cetyl alcohol (UNII: 936JST6JCN)  
Potassium cetyl phosphate (UNII: 03KCY6P7UT)  
SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
PEG-75 stearate (UNII: OT38R0N74H)  
Dimethicone (UNII: 92RU3N3Y1O)  
Product Characteristics
ColorWHITEScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50066-706-011 in 1 CARTON04/22/2020
150 g in 1 JAR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH NOT FINALpart35204/22/2020
Labeler - Genomma Lab USA (832323534)

Revised: 4/2020
Document Id: 6264f2f7-a185-4992-a117-4f20f60dff2e
Set id: abbbc801-3bcc-4cf9-9969-79907dc5fc7a
Version: 1
Effective Time: 20200424
 
Genomma Lab USA